Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
1 |
00000001 - Document - Document and Entity Information |
Network |
* |
* |
http://enterabio.com/role/DocumentAndEntityInformation |
2 |
Implied Table |
Table |
* |
* |
implied:Table |
3 |
Document And Entity Information |
Abstract |
|
|
entx:DocumentAndEntityInformationAbstract |
4 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
5 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
6 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
7 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
8 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
9 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
10 |
Is Entity a Well-known Seasoned Issuer? |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
11 |
Is Entity a Voluntary Filer? |
Concept (Yes/No) |
For Period |
|
dei:EntityVoluntaryFilers |
12 |
Is Entity's Reporting Status Current? |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
13 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
14 |
Entity Shell Company |
Concept (Yes/No) |
For Period |
|
dei:EntityShellCompany |
15 |
Entity Emerging Growth Company |
Concept (Yes/No) |
For Period |
|
dei:EntityEmergingGrowthCompany |
16 |
Entity Transition Period |
Concept (Yes/No) |
For Period |
|
dei:EntityExTransitionPeriod |
17 |
Entity Public Float |
Concept (Monetary) |
As Of |
Credit |
dei:EntityPublicFloat |
18 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
19 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
20 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
21 |
00000002 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfFinancialPosition |
22 |
Implied Table |
Table |
* |
* |
implied:Table |
23 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
24 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
25 |
CURRENT ASSETS: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
26 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
27 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents |
28 |
Accounts receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
29 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentFinancialAssets |
30 |
TOTAL CURRENT ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
31 |
NON-CURRENT ASSETS: |
Abstract |
|
|
ifrs-full:NoncurrentAssetsAbstract |
32 |
Property and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
33 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
34 |
TOTAL NON-CURRENT ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
35 |
TOTAL ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
36 |
Liabilities and shareholders' equity (net of capital deficiency) |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
37 |
CURRENT LIABILITIES: |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
38 |
Accounts payable: |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
39 |
Trade |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
40 |
Other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
41 |
Contract liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentContractLiabilities |
42 |
TOTAL CURRENT LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
43 |
NON-CURRENT LIABILITIES: |
Abstract |
|
|
ifrs-full:NoncurrentLiabilitiesAbstract |
44 |
Convertible loan |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
45 |
Preferred shares |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesValue |
46 |
Warrants to purchase ordinary shares and preferred shares |
Concept (Monetary) |
As Of |
Credit |
entx:WarrantsToPurchaseOrdinarySharesAndPreferredShares |
47 |
Liability to issue preferred shares and warrants |
Concept (Monetary) |
As Of |
Credit |
entx:LiabilityToIssuePreferredSharesAndWarrants |
48 |
Severance pay obligations, net |
Concept (Monetary) |
As Of |
Credit |
entx:SeverancePayObligationsNet |
49 |
TOTAL NON-CURRENT LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
50 |
TOTAL LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
51 |
COMMITMENTS AND CONTINGENCIES |
Concept (Monetary) |
As Of |
Credit |
entx:CommitmentAndContingencies |
52 |
SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY): |
Abstract |
|
|
ifrs-full:EquityAbstract |
53 |
Ordinary Shares, NIS 0.0000769 par value: Authorized - as of December 31, 2018 and December 31, 2017, 140,010,000 and 130,000,000 shares, respectively; issued and outstanding: as of December 31, 2018, and December 31, 2017-11,459,780 and 4,490,720 shares, respectively |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
54 |
Accumulated other comprehensive income |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccumulatedOtherComprehensiveIncome |
55 |
Other reserves |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherReserves |
56 |
Additional paid in capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AdditionalPaidinCapital |
57 |
Accumulated deficit |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
58 |
TOTAL SHAREHOLDERS' EQUITY (CAPITAL DEFICIENCY) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
59 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (NET OF CAPITAL DEFICIENCY) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
60 |
00000003 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) |
Network |
* |
* |
http://enterabio.com/role/StatementsOfFinancialPositionParenthetical |
61 |
Implied Table |
Table |
* |
* |
implied:Table |
62 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
63 |
Ordinary Shares, par value |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
64 |
Ordinary Shares, Authorized |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesAuthorised |
65 |
Ordinary Shares, Issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
66 |
Ordinary Shares, Outstanding |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
67 |
00000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfComprehensiveLoss |
68 |
Implied Table |
Table |
* |
* |
implied:Table |
69 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
70 |
REVENUE |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
71 |
RESEARCH AND DEVELOPMENT EXPENSES, NET |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
72 |
GENERAL AND ADMINISTRATIVE EXPENSES |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GeneralAndAdministrativeExpense |
73 |
OPERATING LOSS |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
74 |
FINANCIAL INCOME: |
Abstract |
|
|
entx:FinancialIncomeAbstract |
75 |
Income from change in fair value of financial liabilities at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
entx:IncomeFromChangeInFairValueOfFinancialLiabilitiesAtFairValueThroughProfitAndLoss |
76 |
Other financial expenses (income), net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherFinanceCost |
77 |
FINANCIAL INCOME, net |
Concept (Monetary) |
For Period |
Debit |
entx:FinancialExpensesIncomeNet |
78 |
NET COMPREHENSIVE LOSS |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
79 |
LOSS PER ORDINARY SHARE - |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
80 |
Basic |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
81 |
Diluted |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
82 |
WEIGHTED AVERAGE NUMBER OF ORDINARY SHARES - |
Abstract |
|
|
ifrs-full:WeightedAverageSharesAndAdjustedWeightedAverageSharesAbstract |
83 |
Basic |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
84 |
Diluted |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
85 |
00000005 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (CHANGES IN CAPITAL DEFICIENCY) |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfShareholdersEquityChangesInCapitalDeficiency |
86 |
Statement of changes in equity [table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
87 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
88 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
89 |
Number of ordinary shares [Member] |
Member |
|
|
ifrs-full:IssuedCapitalMember |
90 |
Accumulated other comprehensive income [Member] |
Member |
|
|
ifrs-full:AccumulatedOtherComprehensiveIncomeMember |
91 |
Other reserves [Member] |
Member |
|
|
ifrs-full:OtherReservesMember |
92 |
Additional paid in capital [Member] |
Member |
|
|
ifrs-full:AdditionalPaidinCapitalMember |
93 |
Accumulated deficit [Member] |
Member |
|
|
ifrs-full:RetainedEarningsMember |
94 |
Statement of changes in equity [line items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
95 |
BALANCE |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
96 |
BALANCE, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
97 |
CHANGES DURING THE YEAR ENDED DECEMBER 31 |
Abstract |
|
|
ifrs-full:ChangesInEquityAbstract |
98 |
Issuance of shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
99 |
Issuance of shares, shares |
Concept (Shares) |
For Period |
|
entx:IssueOfEquityShares |
100 |
Loss for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
101 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
102 |
Issuance of shares and warrants, net |
Concept (Monetary) |
For Period |
Credit |
entx:IssuanceOfSharesAndWarrantsNet |
103 |
Issuance of shares and warrants, net, shares |
Concept (Shares) |
For Period |
|
entx:IssuanceOfSharesAndWarrantsNetShares |
104 |
Conversion of Preferred shares into Ordinary shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfPreferredSharesIntoOrdinaryShares |
105 |
Conversion of Preferred shares into Ordinary shares, shares |
Concept (Shares) |
For Period |
|
entx:ConversionOfPreferredSharesIntoOrdinarySharesInShares |
106 |
Conversion of convertible loan into Ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
107 |
Conversion of convertible loan into Ordinary shares, shares |
Concept (Shares) |
For Period |
|
entx:IncreaseDecreaseThroughConversionOfConvertibleInstrumentsShares |
108 |
Classification of Warrants to purchase preferred shares and shares into Warrants to purchase ordinary shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfWarrantsToPurchasePreferredSharesAndSharesIntoWarrantsToPurchaseOrdinarySharesAndShares |
109 |
Reclassification due to share-based compensation expired |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions |
110 |
Exercise of option to ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions |
111 |
Exercise of option to ordinary shares, shares |
Concept (Shares) |
For Period |
|
entx:IncreaseDecreaseThroughExerciseOfWarrantsEquityShares |
112 |
Reclassification of capital contribution from controlling shareholder (note 7a) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners |
113 |
BALANCE |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
114 |
BALANCE, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
115 |
00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS |
Network |
* |
* |
http://enterabio.com/role/ConsolidatedStatementsOfCashFlows |
116 |
Implied Table |
Table |
* |
* |
implied:Table |
117 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
118 |
CASH FLOWS USED IN OPERATING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
119 |
Loss for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
120 |
Adjustments required to reflect net cash used in operating activities (see appendix A) |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
121 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
122 |
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
123 |
Decrease (increase) in restricted deposits |
Concept (Monetary) |
For Period |
Debit |
entx:CashFlowsFromUsedInDecreaseIncreaseInRestrictedDeposits |
124 |
Purchase of short-term bank deposits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInDepositsFromBanks |
125 |
Purchase of property and equipment |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
126 |
Net cash provided by (used in) investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
127 |
CASH FLOWS PROVIDED BY FINANCING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
128 |
Issuance of ordinary shares and tradable warrants, net of issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfOrdinaryShares |
129 |
Proceeds from convertible loan and warrants, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
130 |
Proceeds from issuance of preferred shares and warrants, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
131 |
Payment for maturity of Convertible loans |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities |
132 |
Net cash generated from financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
133 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents |
134 |
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
135 |
CASH AND CASH EQUIVALENTS AT END OF THE YEAR |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
136 |
Adjustments required to reflect net cash used in operating activities: |
Abstract |
|
|
entx:AdjustmentsRequiredToReflectNetCashUsedInOperatingActivitiesAbstract |
137 |
Depreciation and amortization |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationAndAmortisationExpense |
138 |
Income from change in fair value of financial liabilities at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
entx:IncomeFromChangeInFairValueOfFinancialLiabilitiesAtFairValueThroughProfitAndLoss |
139 |
Issuance costs |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForIssuanceCostsRelatedToOrdinarySharesPreferredSharesConvertibleLoanAndWarrants |
140 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForFinanceCosts |
141 |
Net changes in severance pay obligation |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForNetChangesInSeverancePay |
142 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
143 |
Total adjustments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForReconcileProfitLoss |
144 |
Changes in working capital: |
Abstract |
|
|
entx:ChangesInWorkingCapitalAbstract |
145 |
Decrease (increase) in other current assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets |
146 |
(Increase) decrease in accounts receivable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable |
147 |
Increase (decrease) in accounts payable: |
Abstract |
|
|
entx:IncreaseDecreasesInAccountsPayableAbstract |
148 |
Trade |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable |
149 |
Other |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables |
150 |
Increase in contract liabilities |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForIncreaseDecreaseInContractLiabilities |
151 |
Changes in working capital |
Concept (Monetary) |
For Period |
Debit |
entx:AdjustmentsForChangesInWorkingCapital |
152 |
Cash used for operating activities - |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
153 |
Interest paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestPaidClassifiedAsOperatingActivities |
154 |
Cash used for operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
155 |
Supplementary information on financing activities not involving cash flows: |
Abstract |
|
|
entx:SupplementaryInformationOnFinancingActivitiesNotInvolvingCashFlowsAbstract |
156 |
Conversion of preferred shares into ordinary shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfPreferredSharesIntoOrdinaryShares |
157 |
Conversion of convertible loan into ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
158 |
00000007 - Disclosure - GENERAL INFORMATION |
Network |
* |
* |
http://enterabio.com/role/GeneralInformation |
159 |
Implied Table |
Table |
* |
* |
implied:Table |
160 |
Disclosure of general information [abstract] |
Abstract |
|
|
entx:DisclosureOfGeneralInformationAbstract |
161 |
GENERAL INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory |
162 |
00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Network |
* |
* |
http://enterabio.com/role/SummaryOfSignificantAccountingPolicies |
163 |
Implied Table |
Table |
* |
* |
implied:Table |
164 |
Disclosure of summary of significant accounting policies [abstract] |
Abstract |
|
|
entx:DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract |
165 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
166 |
00000009 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
Network |
* |
* |
http://enterabio.com/role/CriticalAccountingEstimatesAndJudgements |
167 |
Implied Table |
Table |
* |
* |
implied:Table |
168 |
Disclosure of critical accounting estimates and judgements [abstract] |
Abstract |
|
|
entx:DisclosureOfCriticalAccountingEstimatesAndJudgementsAbstract |
169 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
170 |
00000010 - Disclosure - FINANCIAL INSTRUMENTS |
Network |
* |
* |
http://enterabio.com/role/FinancialInstruments |
171 |
Implied Table |
Table |
* |
* |
implied:Table |
172 |
Disclosure of detailed information about financial instruments [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
173 |
FINANCIAL INSTRUMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
174 |
00000011 - Disclosure - CASH AND CASH EQUIVALENTS |
Network |
* |
* |
http://enterabio.com/role/CashAndCashEquivalents |
175 |
Implied Table |
Table |
* |
* |
implied:Table |
176 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
177 |
CASH AND CASH EQUIVALENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory |
178 |
00000012 - Disclosure - INTANGIBLE ASSETS |
Network |
* |
* |
http://enterabio.com/role/IntangibleAssets |
179 |
Implied Table |
Table |
* |
* |
implied:Table |
180 |
Disclosure of detailed information about intangible assets [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfIntangibleAssetsAbstract |
181 |
INTANGIBLE ASSETS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsExplanatory |
182 |
00000013 - Disclosure - CONVERTIBLE LOANS |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoans |
183 |
Implied Table |
Table |
* |
* |
implied:Table |
184 |
Disclosure of detailed information about borrowings [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract |
185 |
CONVERTIBLE LOANS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBorrowingsExplanatory |
186 |
00000014 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedShares |
187 |
Implied Table |
Table |
* |
* |
implied:Table |
188 |
Disclosure of preferred shares and warrants to prefered shares [abstract] |
Abstract |
|
|
entx:DisclosureOfPreferredSharesAndWarrantsToPreferedSharesAbstract |
189 |
PREFERRED SHARES AND WARRANTS TO PREFERED SHARES |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfPreferredSharesAndWarrantsToPreferedSharesExplanatory |
190 |
00000015 - Disclosure - COMMITMENTS |
Network |
* |
* |
http://enterabio.com/role/Commitments |
191 |
Implied Table |
Table |
* |
* |
implied:Table |
192 |
Disclosure of contingent liabilities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfContingentLiabilitiesAbstract |
193 |
COMMITMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsExplanatory |
194 |
00000016 - Disclosure - SHARE CAPITAL |
Network |
* |
* |
http://enterabio.com/role/ShareCapital |
195 |
Implied Table |
Table |
* |
* |
implied:Table |
196 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
197 |
SHARE CAPITAL |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
198 |
00000017 - Disclosure - TAXES ON INCOME |
Network |
* |
* |
http://enterabio.com/role/TaxesOnIncome |
199 |
Implied Table |
Table |
* |
* |
implied:Table |
200 |
Major components of tax expense (income) [abstract] |
Abstract |
|
|
ifrs-full:MajorComponentsOfTaxExpenseIncomeAbstract |
201 |
TAXES ON INCOME |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
202 |
00000018 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS |
Network |
* |
* |
http://enterabio.com/role/RevenueFromContractsWithCustomers |
203 |
Implied Table |
Table |
* |
* |
implied:Table |
204 |
Receivables from contracts with customers [abstract] |
Abstract |
|
|
ifrs-full:ReceivablesFromContractsWithCustomersAbstract |
205 |
REVENUE FROM CONTRACTS WITH CUSTOMERS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory |
206 |
00000019 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformation |
207 |
Implied Table |
Table |
* |
* |
implied:Table |
208 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
209 |
SUPPLEMENTARY FINANCIAL INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfSupplementaryFinancialInformationExplanatory |
210 |
00000020 - Disclosure - BASIC AND DILUTED LOSS PER SHARE |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShare |
211 |
Implied Table |
Table |
* |
* |
implied:Table |
212 |
Basic and diluted earnings per share [abstract] |
Abstract |
|
|
ifrs-full:BasicAndDilutedEarningsPerShareAbstract |
213 |
BASIC AND DILUTED LOSS PER SHARE |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
214 |
00000021 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalances |
215 |
Implied Table |
Table |
* |
* |
implied:Table |
216 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
217 |
RELATED PARTIES - TRANSACTIONS AND BALANCES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
218 |
00000022 - Disclosure - SUBSEQUENT EVENTS |
Network |
* |
* |
http://enterabio.com/role/SubsequentEvents |
219 |
Implied Table |
Table |
* |
* |
implied:Table |
220 |
Disclosure of non-adjusting events after reporting period [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract |
221 |
SUBSEQUENT EVENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
222 |
00000023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
Network |
* |
* |
http://enterabio.com/role/SummaryOfSignificantAccountingPoliciesPolicies |
223 |
Implied Table |
Table |
* |
* |
implied:Table |
224 |
Disclosure of summary of significant accounting policies [abstract] |
Abstract |
|
|
entx:DisclosureOfSummaryOfSignificantAccountingPoliciesAbstract |
225 |
Basis of preparation of the financial statements |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForBasisOfPreparationOfFinancialStatementsExplanatory |
226 |
Functional and presentation currency |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory |
227 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
entx:BasisOfConsolidationPolicyTextBlock |
228 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents |
229 |
Short-term bank deposits |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForShortTermBankDepositsExplanatory |
230 |
Restricted deposits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory |
231 |
Property and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
232 |
Intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory |
233 |
Impairment of non-financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory |
234 |
Segment reporting |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
235 |
Financial instrument |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
236 |
Financial Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory |
237 |
Share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
238 |
Deferred income tax |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory |
239 |
Share-based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
240 |
Revenue recognition |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue |
241 |
Cost of revenues |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForCostOfRevenues |
242 |
Government grants |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants |
243 |
Loss per ordinary share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
244 |
Newly issued and recently adopted Accounting Pronouncements |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForNewlyIssuedAndRecentlyAdoptedAccountingPronouncements |
245 |
New standards, amendments to standards or interpretations |
Concept (Text Block (HTML)) |
For Period |
|
entx:DescriptionOfAccountingPolicyForNewStandardsAmendmentsToStandardsOrInterpretationsExplanatory |
246 |
00000024 - Disclosure - FINANCIAL INSTRUMENTS (Tables) |
Network |
* |
* |
http://enterabio.com/role/FinancialInstrumentsTables |
247 |
Implied Table |
Table |
* |
* |
implied:Table |
248 |
Disclosure of detailed information about financial instruments [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
249 |
Schedule of Classification of Financial Instruments by Groups |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory |
250 |
00000025 - Disclosure - CASH AND CASH EQUIVALENTS (Tables) |
Network |
* |
* |
http://enterabio.com/role/CashAndCashEquivalentsTables |
251 |
Implied Table |
Table |
* |
* |
implied:Table |
252 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
253 |
Schedule of Cash and Cash Equivalents |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory |
254 |
00000026 - Disclosure - CONVERTIBLE LOANS (Tables) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansTables |
255 |
Implied Table |
Table |
* |
* |
implied:Table |
256 |
Disclosure of detailed information about borrowings [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract |
257 |
Schedule of Convertible Components |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutConvertibleComponentsExplanatory |
258 |
Schedule of Convertible Loans |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory |
259 |
00000027 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES (Tables) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesTables |
260 |
Implied Table |
Table |
* |
* |
implied:Table |
261 |
Disclosure of preferred shares and warrants to prefered shares [abstract] |
Abstract |
|
|
entx:DisclosureOfPreferredSharesAndWarrantsToPreferedSharesAbstract |
262 |
Schedule of Movements in Three Components |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutMovementsInThreeComponentsExplanatory |
263 |
Schedule of Valuations of Fair Value of Instruments |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutValuationsOfFairValueOfInstrumentsExplanatory |
264 |
00000028 - Disclosure - SHARE CAPITAL (Tables) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalTables |
265 |
Implied Table |
Table |
* |
* |
implied:Table |
266 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
267 |
Schedule of Composition of Ordinary Shares |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
268 |
Schedule of Weighted Average Assumptions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory |
269 |
Schedule of Changes in Number of Options and Weighted Average Exercise Prices |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory |
270 |
Schedule of Information about Exercise Price and Remaining Contractual Life of Outstanding Options |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory |
271 |
00000029 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables) |
Network |
* |
* |
http://enterabio.com/role/RevenueFromContractsWithCustomersTables |
272 |
Implied Table |
Table |
* |
* |
implied:Table |
273 |
Receivables from contracts with customers [abstract] |
Abstract |
|
|
ifrs-full:ReceivablesFromContractsWithCustomersAbstract |
274 |
Schedule of Revenues |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory |
275 |
00000030 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION (Tables) |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformationTables |
276 |
Implied Table |
Table |
* |
* |
implied:Table |
277 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
278 |
Schedule of Other Current Assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory |
279 |
Schedule of Accounts Payable Other |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
280 |
00000031 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Tables) |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShareTables |
281 |
Implied Table |
Table |
* |
* |
implied:Table |
282 |
Basic and diluted earnings per share [abstract] |
Abstract |
|
|
ifrs-full:BasicAndDilutedEarningsPerShareAbstract |
283 |
Schedule of Basic and Diluted Loss Per Share |
Concept (Text Block (HTML)) |
For Period |
|
entx:DisclosureOfDetailedInformationAboutBasicAndDilutedLossPerShareExplanatory |
284 |
00000032 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Tables) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesTables |
285 |
Implied Table |
Table |
* |
* |
implied:Table |
286 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
287 |
Schedule of Transactions with Related Parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory |
288 |
Schedule of Balances with Related Parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory |
289 |
00000033 - Disclosure - GENERAL INFORMATION (Details) |
Network |
* |
* |
http://enterabio.com/role/GeneralInformationDetails |
290 |
Statement Table [Table] |
Table |
* |
* |
entx:IfrsStatementTable |
291 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
292 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
293 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
294 |
Non-adjusting events after reporting period [Axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
295 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
296 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
297 |
Statement Line Items [Line Items] |
LineItems |
|
|
entx:IfrsStatementLineItems |
298 |
Accumulated losses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
299 |
Revenues generated from research collaboration and license agreement |
Concept (Monetary) |
For Period |
Credit |
entx:RevenuesGeneratedFromResearchCollaborationAndLicenseAgreement |
300 |
Amount to be paid for preclinical services |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ServicesExpense |
301 |
Non-refundable and non-creditable initial technology access fee payment |
Concept (Monetary) |
For Period |
Debit |
entx:NonrefundableAndNoncreditableInitialTechnologyAccessFeePayment |
302 |
00000034 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) |
Network |
* |
* |
http://enterabio.com/role/SummaryOfSignificantAccountingPoliciesDetails |
303 |
Statement Table [Table] |
Table |
* |
* |
entx:IfrsStatementTable |
304 |
Non-adjusting events after reporting period [Axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
305 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
306 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
307 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
308 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
309 |
Statement Line Items [Line Items] |
LineItems |
|
|
entx:IfrsStatementLineItems |
310 |
Short-term bank deposits annual interest rate |
Concept (Percent) |
For Period |
|
entx:ShorttermBankDepositsAnnualInterestRate |
311 |
Initial technology access fee |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:LicenceFeeIncome |
312 |
Non-refundable and non-creditable initial technology access fee payment, including payment for the first year of preclinical services |
Concept (Monetary) |
For Period |
Debit |
entx:NonrefundableAndNoncreditableInitialTechnologyAccessFeePayment |
313 |
Amount of performance obligations |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations |
314 |
Additional amount paid for services to be recognized upon commencement of the pre-clinical Research and Development services |
Concept (Monetary) |
As Of |
Debit |
entx:AdditionalAmountPaidForServicesToBeRecognized |
315 |
Revenue from contract with customer |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
316 |
Contract liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContractLiabilities |
317 |
Account receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeReceivables |
318 |
Increase in Right-of-use assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RightofuseAssetsIncreaseDecreaseInRevaluationSurplus |
319 |
Discount rate used for measuring lease liability |
Concept (Percent) |
As Of |
|
ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 |
320 |
Government grants as financial liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:GovernmentGrants |
321 |
Operating lease commitments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed |
322 |
Right-of-use assets and lease liabilities |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RightofuseAssets |
323 |
Repayment of principal portion of lease liabilities |
Concept (Monetary) |
For Period |
Debit |
entx:RepaymentOfPrincipalPortionOfLeaseLiabilities |
324 |
00000035 - Disclosure - FINANCIAL INSTRUMENTS (Schedule of Classification of Financial Instruments by Groups - Assets) (Details) |
Network |
* |
* |
http://enterabio.com/role/FinancialInstrumentsScheduleOfClassificationOfFinancialInstrumentsByGroups-AssetsDetails |
325 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
326 |
Classes of financial instruments [Axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialInstrumentsAxis |
327 |
Financial instruments, class [member] |
Member |
|
|
ifrs-full:ClassesOfFinancialInstrumentsMember |
328 |
Financial Instruments [Member] |
Member |
|
|
entx:FinancialInstrumentsMember |
329 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
330 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
331 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsNotClassifiedAsCashEquivalents |
332 |
Receivables (excluding prepaid expenses) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentReceivables |
333 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
334 |
00000036 - Disclosure - FINANCIAL INSTRUMENTS (Schedule of Classification of Financial Instruments by Groups - Liabilities) (Details) |
Network |
* |
* |
http://enterabio.com/role/FinancialInstrumentsScheduleOfClassificationOfFinancialInstrumentsByGroups-LiabilitiesDetails |
335 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
336 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
337 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
338 |
Financial liabilities at fair value through profit or loss [Member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtFairValueMember |
339 |
Financial liabilities at amortized cost [Member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesAtAmortisedCostMember |
340 |
Categories of financial assets [axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialAssetsAxis |
341 |
Financial assets, category [member] |
Member |
|
|
ifrs-full:FinancialAssetsCategoryMember |
342 |
Disclosure of detailed information about financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
343 |
Trade and other payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherPayables |
344 |
Convertible loans (Level 3) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
345 |
Preferred shares (Level 3) |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesValue |
346 |
Warrants to purchase ordinary shares |
Concept (Monetary) |
As Of |
Credit |
entx:WarrantsToPurchaseOrdinaryShares |
347 |
Warrants to purchase preferred shares and shares (Level 3) |
Concept (Monetary) |
As Of |
Credit |
entx:WarrantsToPurchasePreferredSharesAndShares |
348 |
Liability to issue preferred shares and warrants |
Concept (Monetary) |
As Of |
Credit |
entx:LiabilityToIssuePreferredSharesAndWarrants |
349 |
Financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
350 |
00000037 - Disclosure - CASH AND CASH EQUIVALENTS (Schedule of Cash and Cash Equivalents) (Details) |
Network |
* |
* |
http://enterabio.com/role/CashAndCashEquivalentsScheduleOfCashAndCashEquivalentsDetails |
351 |
Implied Table |
Table |
* |
* |
implied:Table |
352 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
353 |
Cash in bank |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:BalancesWithBanks |
354 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents |
355 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
356 |
Interest rate on deposits |
Concept (Percent) |
As Of |
|
entx:DepositsInterestRate |
357 |
00000038 - Disclosure - INTANGIBLE ASSETS (Details) |
Network |
* |
* |
http://enterabio.com/role/IntangibleAssetsDetails |
358 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
359 |
Joint ventures [axis] |
Axis |
|
|
ifrs-full:JointVenturesAxis |
360 |
Entity's total for joint ventures [member] |
Member |
|
|
ifrs-full:EntitysTotalForJointVenturesMember |
361 |
D.N.A. and Oramed [Member] |
Member |
|
|
entx:DNAandOramedMember |
362 |
D.N.A. Biomedical Solutions Ltd. [Member] |
Member |
|
|
entx:DNABiomedicalSolutionsLtdMember |
363 |
Oramed [Member] |
Member |
|
|
entx:OramedMember |
364 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
365 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
366 |
Preference Shares Series B [Member] |
Member |
|
|
entx:PreferenceSharesSeriesBMember |
367 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
368 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
369 |
Bottom of range [Member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
370 |
Top of range [Member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
371 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
372 |
Percentage of ordinary shares |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInJointVenture |
373 |
Amount invested in joint venture |
Concept (Monetary) |
For Period |
Debit |
entx:ProportionOfAmountInvestedInJointVenture |
374 |
Percentage of royalties to be paid |
Concept (Percent) |
As Of |
|
entx:PercentageOfRoyaltiesToBePaid |
375 |
Price per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
376 |
Percentage of weighted average cost of capital |
Concept (Percent) |
For Period |
|
ifrs-full:WeightedAverageCostOfCapitalSignificantUnobservableInputsLiabilities |
377 |
Commencement of sales years |
Concept (Text/String) |
For Period |
|
entx:DescriptionOfCommencementOfSalesYears |
378 |
Percentage of probability of reaching sales |
Concept (Percent) |
For Period |
|
ifrs-full:PercentageOfEntitysRevenue |
379 |
00000039 - Disclosure - CONVERTIBLE LOANS (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansNarrativeDetails |
380 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
381 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
382 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
383 |
2012 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2012Member |
384 |
2015 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2015Member |
385 |
Converted to 2016 Loans [Member] |
Member |
|
|
entx:NewConvertibleLoan2016Member |
386 |
2016 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2016Member |
387 |
Joint ventures [axis] |
Axis |
|
|
ifrs-full:JointVenturesAxis |
388 |
Entity's total for joint ventures [member] |
Member |
|
|
ifrs-full:EntitysTotalForJointVenturesMember |
389 |
D.N.A [Member] |
Member |
|
|
entx:DNAMember |
390 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
391 |
Borrowings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
392 |
Interest rate |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
393 |
Maturity |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
394 |
Conversion price per share |
Concept (Share) |
For Period |
|
entx:ConversionPricePerShare |
395 |
Convertible loan converted into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConvertibleLoanConvertedIntoOrdinaryShares |
396 |
Number of ordinary shares exchanged |
Concept (Shares) |
For Period |
|
entx:NumberOfOrdinarySharesExchanged |
397 |
Number of stock merged |
Concept (Shares) |
For Period |
|
entx:NumberOfStockMerged |
398 |
Discount to the applicable price per share in the triggering event |
Concept (Percent) |
As Of |
|
ifrs-full:DescriptionOfDiscountRatesUsedInCurrentEstimateOfValueInUse |
399 |
Percentage of warrants to purchase additional shares on conversion |
Concept (Percent) |
For Period |
|
entx:PercentageOfWarrantsToPurchaseAdditionalSharesOnConversion |
400 |
Finance expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
401 |
Repayments of borrowings |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfNoncurrentBorrowings |
402 |
Deposit amount at trustee |
Concept (Monetary) |
As Of |
Debit |
entx:DepositAmountAtTrustee |
403 |
Description of automatically converted loan to shares |
Concept (Text/String) |
For Period |
|
entx:DescriptionOfAutomaticallyConvertedLoanToShares |
404 |
Exercisable period of warrants |
Concept (Text/String) |
For Period |
|
entx:DescriptionOfExercisablePeriodOfWarrants |
405 |
Transaction expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
406 |
Amount payable in shares |
Concept (Monetary) |
For Period |
Debit |
entx:AmountPayableInShares |
407 |
Convertible loan and accrued interest converted into series B-1 preferred shares |
Concept (Shares) |
For Period |
|
entx:ConvertibleLoanAndAccruedInterestConvertedIntoSeriesB1PreferredShares |
408 |
Exercise price of warrants |
Concept (Share) |
For Period |
|
entx:ExercisePriceOfWarrants |
409 |
Stock split |
Concept (Text/String) |
For Period |
|
entx:StockSplit |
410 |
Conversion of convertible loan into Ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
411 |
00000040 - Disclosure - CONVERTIBLE LOANS (Schedule of Convertible Components) (Details) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansScheduleOfConvertibleComponentsDetails |
412 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
413 |
Liabilities arising from financing activities [axis] |
Axis |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis |
414 |
Liabilities arising from financing activities [member] |
Member |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesMember |
415 |
Convertible loans [Member] |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
416 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
417 |
Price per share |
Concept (Share) |
As Of |
|
entx:PricePerShare |
418 |
Volatility |
Concept (Percent) |
As Of |
|
entx:DescriptionOfExpectedVolatilityOfConvertibleLoans |
419 |
Probability of entering Phase 2b/3 |
Concept (Percent) |
As Of |
|
entx:ProbabilityOfEnteringPhase2b3 |
420 |
Probability for IPO |
Concept (Percent) |
As Of |
|
entx:ProbabilityForIPO |
421 |
00000041 - Disclosure - CONVERTIBLE LOANS (Schedule of Convertible Loans) (Details) |
Network |
* |
* |
http://enterabio.com/role/ConvertibleLoansScheduleOfConvertibleLoansDetails |
422 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
423 |
Liabilities arising from financing activities [axis] |
Axis |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis |
424 |
Liabilities arising from financing activities [member] |
Member |
|
|
ifrs-full:LiabilitiesArisingFromFinancingActivitiesMember |
425 |
Convertible loans [Member] |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
426 |
Warrants to purchase preferred shares and shares [Member] |
Member |
|
|
entx:WarrantsToPurchasePreferredSharesAndSharesMember |
427 |
Levels Of Fair Value Hierarchy [Axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
428 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
429 |
Level 3 [Member] |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
430 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
431 |
Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
432 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromNoncurrentBorrowings |
433 |
Maturity during period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfNoncurrentBorrowings |
434 |
Conversion to Series B-1 preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionToSeriesBOnePreferredShares |
435 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
436 |
Changes in fair value |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ChangesInFairValueOfLoansOrReceivablesAttributableToChangesInCreditRiskOfFinancialAssets |
437 |
Changes in fair value up to IPO |
Concept (Monetary) |
For Period |
Debit |
entx:ChangesInFairValueOfLoansOrReceivablesAttributableToChangesInCreditRiskOfFinancialAssetsUpToInitialPublicOffering |
438 |
Conversion into Ordinary shares on IPO (see Note 10b) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
439 |
Conversion to warrants to purchase Series B preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionToWarrantsToPurchaseSeriesBPreferredShares |
440 |
Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
441 |
00000042 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesNarrativeDetails |
442 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
443 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
444 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
445 |
Centillion preferred share purchase agreement [Member] |
Member |
|
|
entx:CentillionPreferredSharePurchaseAgreementMember |
446 |
Additional Centillion preferred share purchase agreement [Member] |
Member |
|
|
entx:AdditionalCentillionPreferredSharePurchaseAgreementMember |
447 |
Second amendment to Centillion preferred share purchase agreement [Member] |
Member |
|
|
entx:SecondAmendmentToCentillionPreferredSharePurchaseAgreementMember |
448 |
Preferred Shares Series B- 1 [Member] |
Member |
|
|
entx:PreferenceSharesSeriesB1Member |
449 |
Series A preferred shares [Member] |
Member |
|
|
entx:SeriesAPreferredSharesMember |
450 |
Series B preferred shares [Member] |
Member |
|
|
entx:SeriesBPreferredSharesMember |
451 |
Warrants [Member] |
Member |
|
|
entx:WarrantsMember |
452 |
Separate management entities [axis] |
Axis |
|
|
ifrs-full:SeparateManagementEntitiesAxis |
453 |
Separate management entities [member] |
Member |
|
|
ifrs-full:SeparateManagementEntitiesMember |
454 |
Investors [Member] |
Member |
|
|
entx:InvestorsMember |
455 |
Broker dealer [Member] |
Member |
|
|
entx:BrokerDealerMember |
456 |
Mr. Luke Beshar [Member] |
Member |
|
|
entx:LukeBesharMember |
457 |
Dr. Graceau [Member] |
Member |
|
|
entx:RogerGraceauMember |
458 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
459 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
460 |
2016 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2016Member |
461 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
462 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
463 |
Related parties [member] |
Member |
|
|
ifrs-full:RelatedPartiesMember |
464 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
465 |
Number of preferred shares purchased |
Concept (Shares) |
For Period |
|
entx:NumberOfPreferredSharesPurchased |
466 |
Number of preferred shares purchased, value |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfPreferenceShares |
467 |
Number of preferred shares purchased, price per share |
Concept (Share) |
For Period |
|
entx:NumberOfPreferredSharesPurchasedPricePerShare |
468 |
Warrants issued to purchase shares |
Concept (Shares) |
For Period |
|
entx:WarrantsIssuedToPurchaseShares |
469 |
Fair value of preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:FairValueOfPreferredShares |
470 |
Fair value of warrants |
Concept (Monetary) |
For Period |
Debit |
entx:FairValueOfWarrants |
471 |
Percentage of discount applicable to price per share |
Concept (Percent) |
For Period |
|
entx:PercentageOfDiscountApplicableToPricePerShare |
472 |
Number of warrants converted into additional warrants to purchase ordinary shares |
Concept (Shares) |
For Period |
|
entx:NumberOfWarrantsConvertedIntoAdditionalWarrantsToPurchaseOrdinaryShares |
473 |
Value of additional warrants issued |
Concept (Monetary) |
For Period |
Credit |
entx:ValueOfAdditionalWarrantsIssued |
474 |
Exercise price of warrants |
Concept (Share) |
For Period |
|
entx:ExercisePriceOfWarrants |
475 |
Total consideration net of issuance costs |
Concept (Monetary) |
For Period |
Debit |
entx:NetProceedsFromIssueOfPreferenceShares |
476 |
Additional issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
477 |
Shares issued in conversion of debt |
Concept (Shares) |
For Period |
|
entx:SharesIssuedInConversionOfDebt |
478 |
Number of preferred shares converted to ordinary shares following closing of IPO |
Concept (Shares) |
For Period |
|
entx:NumberOfPreferredSharesConvertedToOrdinarySharesFollowingClosingOfInitialPublicOfferring |
479 |
Shares issued in conversion of debt, value |
Concept (Monetary) |
For Period |
Credit |
entx:SharesIssuedInConversionOfDebtValue |
480 |
Shares issued in conversion of debt, price per share |
Concept (Share) |
For Period |
|
entx:SharesIssuedInConversionOfDebtPricePerShare |
481 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
482 |
Interest rate on preferred shares |
Concept (Percent) |
For Period |
|
entx:InterestRateOnPreferredShares |
483 |
Conversion into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConversionIntoOrdinaryShares |
484 |
Warrant term |
Concept (Text/String) |
For Period |
|
entx:WarrantTerm |
485 |
Effective price per share |
Concept (Share) |
For Period |
|
entx:EffectivePricePerShare |
486 |
Exceeds sales price per share |
Concept (Share) |
For Period |
|
entx:ExceedsSalesPricePerShare |
487 |
Percentage of per unit price |
Concept (Percent) |
For Period |
|
entx:PercentageOfPerUnitPrice |
488 |
00000043 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARES (Schedule of Movements in Three Components) (Details) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesScheduleOfMovementsInThreeComponentsDetails |
489 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
490 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
491 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
492 |
Preferred shares [Member] |
Member |
|
|
ifrs-full:PreferenceSharesMember |
493 |
Warrants to purchase preferred shares and shares [Member] |
Member |
|
|
entx:WarrantsToPurchasePreferredSharesAndSharesMember |
494 |
Liability to issue preferred shares and warrants [Member] |
Member |
|
|
entx:LiabilityToIssuePreferredSharesAndWarrantsMember |
495 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
496 |
Balance |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesAndWarrantsToPreferedShares |
497 |
Issuance of Series B preferred shares and warrants to purchase Series B preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:IssuanceOfSeriesBPreferredSharesAndWarrantsToPurchaseSeriesBPreferredShares |
498 |
Conversion of 2016 Convertible Loan and warrants to series B-1 preferred shares and warrant to purchase Series B preferred shares |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOf2016ConvertibleLoanAndWarrantsToSeriesB1PreferredSharesAndWarrantToPurchaseSeriesBPreferredShares |
499 |
Change of conditions of the liability to issue preferred shares and warrants to warrants |
Concept (Monetary) |
For Period |
Credit |
entx:ChangeOfConditionsOfLiabilityToIssuePreferredSharesAndWarrantsToWarrants |
500 |
Changes in fair value |
Concept (Monetary) |
For Period |
Credit |
entx:ChangesInFairValueOfPreferredSharesWarrantsToPurchasePreferredSharesAndLiabilityToIssuePreferredSharesAndWarrants |
501 |
Conversion of Preferred shares to Ordinary shares on IPO |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfPreferredSharesToOrdinarySharesOnIpo |
502 |
Conversion of Warrants to purchase preferred shares to Warrants to purchase ordinary shares on IPO |
Concept (Monetary) |
For Period |
Credit |
entx:ConversionOfWarrantsToPurchasePreferredSharesToWarrantsToPurchaseOrdinarySharesOnIpo |
503 |
Balance |
Concept (Monetary) |
As Of |
Credit |
entx:PreferredSharesAndWarrantsToPreferedShares |
504 |
00000044 - Disclosure - PREFERRED SHARES AND WARRANTS TO PREFERED SHARE (Schedule of Valuations of Fair Value of Instruments) (Details) |
Network |
* |
* |
http://enterabio.com/role/PreferredSharesAndWarrantsToPreferedSharesAndSharesScheduleOfValuationsOfFairValueOfInstrumentsDetails |
505 |
Disclosure of fair value measurement of assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsTable |
506 |
Levels Of Fair Value Hierarchy [Axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
507 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
508 |
Level 3 [Member] |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
509 |
Disclosure of fair value measurement of assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueMeasurementOfAssetsLineItems |
510 |
Price per share |
Concept (Share) |
As Of |
|
entx:PricePerShare |
511 |
Value of equity |
Concept (Monetary) |
As Of |
Credit |
entx:ValueOfEquity |
512 |
Volatility |
Concept (Percent) |
As Of |
|
entx:DescriptionOfExpectedVolatilityOfConvertibleLoans |
513 |
Probability of entering Phase 2b/3 |
Concept (Percent) |
As Of |
|
entx:ProbabilityOfEnteringPhase2b3 |
514 |
Probability for IPO |
Concept (Percent) |
As Of |
|
entx:ProbabilityForIPO |
515 |
00000045 - Disclosure - COMMITMENTS (Details) |
Network |
* |
* |
http://enterabio.com/role/CommitmentsDetails |
516 |
IfrsStatementsTable [Table] |
Table |
* |
* |
entx:IfrsStatementsTable |
517 |
Non-adjusting events after reporting period [Axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
518 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
519 |
Amgen Inc [Member] |
Member |
|
|
entx:AmgenIncMember |
520 |
Statement Line Items [Line Items] |
LineItems |
|
|
entx:IfrsStatementLineItems |
521 |
Lease expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense |
522 |
Lease expiration period |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfMaterialLeasingArrangementsByLesseeClassifiedAsOperatingLease |
523 |
Percentage of royalty payable on sales of products developed during first three years |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnSalesOfProductsDevelopedDuringFirstThreeYears |
524 |
Percentage of royalty payable on sales of products developed during subsequent three years |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnSalesOfProductsDevelopedDuringSubsequentThreeYears |
525 |
Percentage of royalty payable on sales of products developed during commencing of seventh year |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnSalesOfProductsDevelopedDuringCommencingOfSeventhYear |
526 |
Percentage of royalty payable on grants received by company |
Concept (Percent) |
For Period |
|
entx:PercentageOfRoyaltyPayableOnGrantsReceivedByCompany |
527 |
Royalty amount payable |
Concept (Monetary) |
As Of |
Credit |
entx:RoyaltyAmountPayable |
528 |
Percentage to be paid for each payment received |
Concept (Percent) |
For Period |
|
entx:PercentageOfEachPaymentReceived |
529 |
Amount paid to government of israel |
Concept (Monetary) |
For Period |
Credit |
entx:AmountPaidToGovernmentOfIsrael |
530 |
00000046 - Disclosure - SHARE CAPITAL (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalNarrativeDetails |
531 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
532 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
533 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
534 |
IPO [Member] |
Member |
|
|
entx:InitialPublicOfferingMember |
535 |
Warrants [Member] |
Member |
|
|
entx:WarrantsMember |
536 |
Ordinary shares [member] |
Member |
|
|
ifrs-full:OrdinarySharesMember |
537 |
Series A preferred shares [Member] |
Member |
|
|
entx:SeriesAPreferredSharesMember |
538 |
Series B preferred shares [Member] |
Member |
|
|
entx:SeriesBPreferredSharesMember |
539 |
Series B-1 preferred shares [Member] |
Member |
|
|
entx:SeriesB1PreferredSharesMember |
540 |
Warrants to series A preferred shares [Member] |
Member |
|
|
entx:WarrantsToSeriesAPreferredSharesMember |
541 |
Warrants to series B preferred shares [Member] |
Member |
|
|
entx:WarrantsToSeriesBPreferredSharesMember |
542 |
Warrants to series B-1 preferred shares [Member] |
Member |
|
|
entx:WarrantsToSeriesB1PreferredSharesMember |
543 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
544 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
545 |
2012 Convertible Loan [Member] |
Member |
|
|
entx:ConvertibleLoan2012Member |
546 |
Separate management entities [axis] |
Axis |
|
|
ifrs-full:SeparateManagementEntitiesAxis |
547 |
Separate management entities [member] |
Member |
|
|
ifrs-full:SeparateManagementEntitiesMember |
548 |
Investors [Member] |
Member |
|
|
entx:InvestorsMember |
549 |
Underwriters [Member] |
Member |
|
|
entx:UnderwritersMember |
550 |
Mr. Luke Beshar [Member] |
Member |
|
|
entx:LukeBesharMember |
551 |
Dr. Graceau [Member] |
Member |
|
|
entx:RogerGraceauMember |
552 |
Dr. Eric Lang [Member] |
Member |
|
|
entx:DrEricLangMember |
553 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
554 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
555 |
Certain Consultant [Member] |
Member |
|
|
entx:CertainConsultantMember |
556 |
Certain Director [Member] |
Member |
|
|
entx:CertainDirectorMember |
557 |
CEO, COO and CFO [Member] |
Member |
|
|
entx:ChiefExecutiveOfficerChiefOperatingOfficerAndChiefFinancialOfficerMember |
558 |
Certain Employees [Member] |
Member |
|
|
entx:CertainEmployeesMember |
559 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
560 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
561 |
Bottom of range [Member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
562 |
Top of range [Member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
563 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
564 |
Stock split |
Concept (Text/String) |
For Period |
|
entx:StockSplit |
565 |
Number of shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
566 |
Warrants issued to purchase shares |
Concept (Shares) |
For Period |
|
entx:WarrantsIssuedToPurchaseShares |
567 |
Warrants converted into ordinary shares |
Concept (Shares) |
For Period |
|
entx:WarrantsConvertedIntoOrdinaryShares |
568 |
Proceeds from issuance of ordinary shares, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssueOfOrdinaryShares |
569 |
Proceeds from issuance of ordinary shares, gross |
Concept (Monetary) |
For Period |
Debit |
entx:ProceedsFromIssueOfOrdinarySharesGross |
570 |
Stock issuance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
571 |
Underwriters fee |
Concept (Monetary) |
For Period |
Debit |
entx:UnderwritersFee |
572 |
Other issuance costs |
Concept (Monetary) |
For Period |
Debit |
entx:OtherIssuanceCosts |
573 |
Exercise price of warrants |
Concept (Share) |
For Period |
|
entx:ExercisePriceOfWarrants |
574 |
Public offering price per unit |
Concept (Share) |
For Period |
|
entx:PublicOfferingPricePerUnit |
575 |
Number of ordinary shares that can be purchased through each tradeable warrant |
Concept (Shares) |
For Period |
|
entx:NumberOfOrdinarySharesThatCanBePurchasedThroughEachTradeableWarrant |
576 |
Convertible loan converted into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConvertibleLoanConvertedIntoOrdinaryShares |
577 |
Conversion into ordinary shares |
Concept (Shares) |
For Period |
|
entx:ConversionIntoOrdinaryShares |
578 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
579 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
580 |
Warrants granted to purchase ordinary shares |
Concept (Shares) |
For Period |
|
entx:WarrantsGrantedToPurchaseOrdinaryShares |
581 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
582 |
Options vesting description |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
583 |
Fair value of options |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
584 |
Fair value of warrants |
Concept (Monetary) |
For Period |
Debit |
entx:FairValueOfWarrants |
585 |
Remaining unrecognized compensation expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
586 |
Percentage of options granted to purchase ordinary shares |
Concept (Percent) |
For Period |
|
entx:PercentageOfOptionsGrantedToPurchaseOrdinaryShares |
587 |
Amount of new funds to be received by Company upon triggering event |
Concept (Monetary) |
For Period |
Credit |
entx:AmountOfNewFundsToBeReceivedUponTriggeringEvent |
588 |
Reserved ordinary shares |
Concept (Shares) |
For Period |
|
entx:ReservedOrdinaryShares |
589 |
Option forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
590 |
Reversal of expense recognized in General and Administrative expense due to forfeiture of options |
Concept (Monetary) |
For Period |
Credit |
entx:ReversalOfExpenseForForfeitureOfOptionsToBoardOfDirectors |
591 |
Intrinsic value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IntrinsicValueOfLiabilitiesFromSharebasedPaymentTransactionsForWhichCounterpartysRightToCashOrOtherAssetsVested2011 |
592 |
00000047 - Disclosure - SHARE CAPITAL (Schedule of Composed of Ordinary Shares) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfComposedOfOrdinarySharesDetails |
593 |
Implied Table |
Table |
* |
* |
implied:Table |
594 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
595 |
Authorized |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesAuthorised |
596 |
Issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
597 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
598 |
00000048 - Disclosure - SHARE CAPITAL (Schedule of Weighted Average Assumptions) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfWeightedAverageAssumptionsDetails |
599 |
Implied Table |
Table |
* |
* |
implied:Table |
600 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
601 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
602 |
Ordinary share price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageSharePriceShareOptionsGranted |
603 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:ExercisePriceShareOptionsGranted |
604 |
Dividend yield |
Concept (Percent) |
For Period |
|
ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted |
605 |
Expected volatility |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted |
606 |
Risk-free interest rate |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted |
607 |
Expected life - in years |
Concept (Decimal) |
For Period |
|
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted |
608 |
00000049 - Disclosure - SHARE CAPITAL (Schedule of Changes in Number of Options and Weighted Average Exercise Prices) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfChangesInNumberOfOptionsAndWeightedAverageExercisePricesDetails |
609 |
Implied Table |
Table |
* |
* |
implied:Table |
610 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
611 |
Number of options |
Abstract |
|
|
entx:NumberOfOutstandingShareOptionsAbstract |
612 |
Outstanding at beginning of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
613 |
Forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
614 |
Exercised |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
615 |
Granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
616 |
Outstanding at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
617 |
Exercisable at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
618 |
Weighted average exercise price |
Abstract |
|
|
entx:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangementAbstract |
619 |
Outstanding at beginning of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
620 |
Forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
621 |
Exercised |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
622 |
Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
623 |
Outstanding at end of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
624 |
Exercisable at end of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
625 |
Intrinsic value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IntrinsicValueOfLiabilitiesFromSharebasedPaymentTransactionsForWhichCounterpartysRightToCashOrOtherAssetsVested2011 |
626 |
00000050 - Disclosure - SHARE CAPITAL (Schedule of Information about Exercise Price and Remaining Contractual Life of Outstanding Options) (Details) |
Network |
* |
* |
http://enterabio.com/role/ShareCapitalScheduleOfInformationAboutExercisePriceAndRemainingContractualLifeOfOutstandingOptionsDetails |
627 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
628 |
Ranges of exercise prices for outstanding share options [axis] |
Axis |
|
|
ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis |
629 |
Ranges of exercise prices for outstanding share options [member] |
Member |
|
|
ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsMember |
630 |
Exercise Price One [Member] |
Member |
|
|
entx:ExercisePriceOneMember |
631 |
Exercise Price Two [Member] |
Member |
|
|
entx:ExercisePriceTwoMember |
632 |
Exercise Price Three [Member] |
Member |
|
|
entx:ExercisePriceThreeMember |
633 |
Exercise Price Four [Member] |
Member |
|
|
entx:ExercisePriceFourMember |
634 |
Exercise Price Five [Member] |
Member |
|
|
entx:ExercisePriceFiveMember |
635 |
Exercise Price Six [Member] |
Member |
|
|
entx:ExercisePriceSixMember |
636 |
Exercise Price Seven [Member] |
Member |
|
|
entx:ExercisePriceSevenMember |
637 |
Exercise Price Eight [Member] |
Member |
|
|
entx:ExercisePriceEightMember |
638 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
639 |
Number of options outstanding at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
640 |
Exercise price |
Concept (Monetary) |
As Of |
|
ifrs-full:ExercisePriceOfOutstandingShareOptions |
641 |
Weighted average of remaining contractual life |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
642 |
00000051 - Disclosure - TAXES ON INCOME (Details) |
Network |
* |
* |
http://enterabio.com/role/TaxesOnIncomeDetails |
643 |
Implied Table |
Table |
* |
* |
implied:Table |
644 |
Major components of tax expense (income) [abstract] |
Abstract |
|
|
ifrs-full:MajorComponentsOfTaxExpenseIncomeAbstract |
645 |
Israel corporate tax rates |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
646 |
Reduction in tax rate |
Concept (Text/String) |
For Period |
|
ifrs-full:ExplanationOfChangesInApplicableTaxRatesToPreviousAccountingPeriod |
647 |
Carryforward losses |
Concept (Monetary) |
As Of |
Debit |
entx:CarryforwardLosses |
648 |
Income tax rate in United states |
Concept (Percent) |
For Period |
|
entx:IncomeTaxRate |
649 |
00000052 - Disclosure - REVENUE FROM CONTRACTS WITH CUSTOMERS (Schedule of Revenues) (Details) |
Network |
* |
* |
http://enterabio.com/role/RevenueFromContractsWithCustomersScheduleOfRevenuesDetails |
650 |
Implied Table |
Table |
* |
* |
implied:Table |
651 |
Receivables from contracts with customers [abstract] |
Abstract |
|
|
ifrs-full:ReceivablesFromContractsWithCustomersAbstract |
652 |
Revenues from license |
Concept (Monetary) |
For Period |
Credit |
entx:RevenueFromLicense |
653 |
Revenues from preclinical research and development |
Concept (Monetary) |
For Period |
Credit |
entx:RevenuesFromPreclinicalResearchAndDevelopment |
654 |
Total revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
655 |
Contract liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContractLiabilities |
656 |
00000053 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION (Schedule of Other Current Assets) (Details) |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformationScheduleOfOtherCurrentAssetsDetails |
657 |
Implied Table |
Table |
* |
* |
implied:Table |
658 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
659 |
Other current assets: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
660 |
Prepaid expenses |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepaidExpenses |
661 |
Restricted deposits |
Concept (Monetary) |
As Of |
Debit |
entx:OtherCurrentRestrictedDeposits |
662 |
Other |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
663 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentFinancialAssets |
664 |
00000054 - Disclosure - SUPPLEMENTARY FINANCIAL INFORMATION (Schedule of Accounts Payable Other) (Details) |
Network |
* |
* |
http://enterabio.com/role/SupplementaryFinancialInformationScheduleOfAccountsPayableOtherDetails |
665 |
Implied Table |
Table |
* |
* |
implied:Table |
666 |
Disclosure of supplementary financial information [abstract] |
Abstract |
|
|
entx:DisclosureOfSupplementaryFinancialInformationAbstract |
667 |
Accounts payable - other: |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
668 |
Employees and employees related |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermEmployeeBenefitsAccruals |
669 |
Provision for vacation |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentProvisions |
670 |
Accrued expenses and other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities |
671 |
Accounts payable - other |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
672 |
00000055 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShareNarrativeDetails |
673 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
674 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
675 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
676 |
2012 Convertible Loan, 2016 Convertible Loan, preferred shares and warrants [Member] |
Member |
|
|
entx:ConvertibleLoan2012ConvertibleLoan2016PreferredSharesAndWarrantsMember |
677 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
678 |
Number of ordinary shares related to the outstanding options excluded from the calculation of diluted loss per share |
Concept (Shares) |
For Period |
|
ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares |
679 |
00000056 - Disclosure - BASIC AND DILUTED LOSS PER SHARE (Schedule of Basic and Diluted Loss Per Share) (Details) |
Network |
* |
* |
http://enterabio.com/role/BasicAndDilutedLossPerShareScheduleOfBasicAndDilutedLossPerShareDetails |
680 |
Implied Table |
Table |
* |
* |
implied:Table |
681 |
Basic and diluted earnings per share [abstract] |
Abstract |
|
|
ifrs-full:BasicAndDilutedEarningsPerShareAbstract |
682 |
Loss attributable to equity holders of the Company |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
683 |
Income from change in fair value of financial liabilities at fair value |
Concept (Monetary) |
For Period |
Credit |
entx:IncomeFromChangeInFairValueOfFinancialLiabilitiesAtFairValue |
684 |
Loss used for the computation of diluted loss per share |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests |
685 |
Weighted average number of Ordinary Shares used in the computation of basic loss per share |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
686 |
Add: Weighted average number of additional shares issuable upon the assumed conversion/exercise of 2012 convertible loan, preferred shares and warrants to issue preferred shares and shares |
Concept (Shares) |
For Period |
|
ifrs-full:IncreaseDecreaseInNumberOfOrdinarySharesIssued |
687 |
Weighted average number of Ordinary Shares used in the computation of diluted loss per share |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
688 |
Basic loss per Ordinary Share |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
689 |
Diluted loss per Ordinary Share |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
690 |
00000057 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Narrative) (Details) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesNarrativeDetails |
691 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
692 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
693 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
694 |
Mr. Luke Beshar [Member] |
Member |
|
|
entx:LukeBesharMember |
695 |
Dr. Graceau [Member] |
Member |
|
|
entx:RogerGraceauMember |
696 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
697 |
Monthly fee |
Concept (Monetary) |
For Period |
Debit |
entx:KeyManagementPersonnelCompensationMonthlyFee |
698 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
699 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
700 |
Options vested |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
701 |
00000058 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Schedule of Transactions with Related Parties) (Details) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesScheduleOfTransactionsWithRelatedPartiesDetails |
702 |
Implied Table |
Table |
* |
* |
implied:Table |
703 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
704 |
Key management compensation: |
Abstract |
|
|
entx:KeyManagementCompensationAbstract |
705 |
Labor cost and related expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
706 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
707 |
Directors fee and services |
Concept (Monetary) |
For Period |
Debit |
entx:KeyManagementPersonnelCompensationDirectorsFeeAndServices |
708 |
Others |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits |
709 |
Key management compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensation |
710 |
00000059 - Disclosure - RELATED PARTIES - TRANSACTIONS AND BALANCES (Schedule of Balances with Related Parties) (Details) |
Network |
* |
* |
http://enterabio.com/role/RelatedParties-TransactionsAndBalancesScheduleOfBalancesWithRelatedPartiesDetails |
711 |
Implied Table |
Table |
* |
* |
implied:Table |
712 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
713 |
Key management: |
Abstract |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract |
714 |
Payables and accrued expenses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AmountsPayableRelatedPartyTransactions |
715 |
Severance pay obligations |
Concept (Monetary) |
As Of |
Credit |
entx:SeverancePayObligationsRelatedPartyTransactions |
716 |
Provision for vacation |
Concept (Monetary) |
As Of |
Credit |
entx:ProvisionForVacationRelatedPartyTransactions |
717 |
Directors fee and services |
Concept (Monetary) |
As Of |
Credit |
entx:DirectorsFeeAndServicesRelatedPartyTransactions |
718 |
00000060 - Disclosure - SUBSEQUENT EVENTS (Details) |
Network |
* |
* |
http://enterabio.com/role/SubsequentEventsDetails |
719 |
Disclosure of non-adjusting events after reporting period [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable |
720 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
721 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
722 |
Certain Employees [Member] |
Member |
|
|
entx:CertainEmployeesMember |
723 |
CMO [Member] |
Member |
|
|
entx:CmoMember |
724 |
Non-executive Directors [Member] |
Member |
|
|
entx:NonExecutiveDirectorsMember |
725 |
Disclosure of non-adjusting events after reporting period [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems |
726 |
Options granted to purchase ordinary shares |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
727 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
728 |
Fair value of options |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
729 |
Options vesting description |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |